Patent · US Active

Treatment of cancer

US8143447B2 · kind B2 · utility

3Cited by
117References
4Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 5, 2007
Grant dateMar 27, 2012
Priority date
Expiry dateJul 18, 2028

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07C239/18
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The present invention provides compositions of matter, kits and methods for their use in the treatment of cancer. In particular, the invention provides compositions and methods for treating cancer in a subject by inhibiting a poly-ADP-ribose polymerase, as well as providing formulations and modes of administering such compositions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.